BMRC
Bank of Marin Bancorp
BMRC has the edge over MS overall, supported by stronger valuation and stronger fundamentals.
MS
Morgan Stanley
MS has slightly lower modeled downside risk, despite its lower overall score.
BMRC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
BMRC's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMRC.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BMRC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.8x | $28.52 | — |
| Cheap | 8.8x | $37.00 | +30% |
| Forward | 11x | $28.52 | — |
| Fair | 14x | $57.55 | +102% |
| Expensive | 18x | $75.08 | +163% |
Historical ranges are pointers, not guarantees.
BMRC has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BMRC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BMRC, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BMRC on the outlook, with more favorable valuation expectations.
BMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.50 | -41% |
| Q3 2026 | $4.22 | +581% |
| Q2 2026 | $4.07 | +847% |
| Q1 2026 | $2.96 | +$3.36 |
| Q4 2025 | $2.73 | +$3.25 |
| Q3 2025 | $0.62 | +$1.48 |
| Q2 2025 | $0.43 | +$1.24 |
| Q1 2025 | -$0.40 | -148% |
| Q4 2024 | -$0.52 | -142% |
BMRC's earnings per share have jumped to their highest in seven years: $4.22 over the past year, up from $0.62 the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BMRC on earnings, with more consistent year-over-year improvement.
BMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.1M | +13% |
| Q2 2026 | $34M | +230% |
| Q1 2026 | $34.1M | +23% |
| Q4 2025 | $79.3M | +183% |
| Q3 2025 | $30.9M | +14% |
| Q2 2025 | $10.3M | +181% |
| Q1 2025 | $27.8M | +9.3% |
| Q4 2024 | $28M | +33% |
BMRC has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.9 points |
| Q2 2026 | 37% | +146 points |
| Q1 2026 | 34% | +11 points |
| Q4 2025 | 59% | +25 points |
| Q3 2025 | 31% | +5.4 points |
| Q2 2025 | -109% | +830 points |
| Q1 2025 | 23% | +7.9 points |
| Q4 2024 | 34% | +33 points |
BMRC has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16M | +33% |
| Q2 2026 | $11.8M | +68% |
| Q1 2026 | $921K | -80% |
| Q4 2025 | $13.2M | +25% |
| Q3 2025 | $12.1M | +24% |
| Q2 2025 | $7.1M | +111% |
| Q1 2025 | $4.6M | +11% |
| Q4 2024 | $10.6M | +1261% |
BMRC has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BMRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +49K shares |
| 1 year | +0.7% | +106K shares |
| 3 years | 0% | +4K shares |
| 5 years | +7% | +1M shares |
| Available history | +16% | +2.2M shares |
BMRC has 16M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6,000 |
| Q1 2026 | $6,000 |
| Q4 2025 | — |
| Q3 2025 | $1.1M |
| Q4 2024 | $19,000 |
| Q2 2024 | $55,000 |
| Q4 2023 | — |
BMRC has spent almost nothing on buybacks in the past year.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over BMRC on shareholder dilution, with a more favorable share count trend.
BMRC Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.3 | Neutral |
| Stochastic | 61.9 | Neutral |
BMRC's weekly RSI is 58 (neutral) and its Stochastic is 62 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BMRC PE vs Financial Services Sector
| Metric | BMRC | Sector median | Relative |
|---|---|---|---|
| PE | 6.8x | 13x | 48% below |
| PE % | 6 | 63 | 57 pts below |
BMRC has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 3.2% above |
| 20 week MA | $27.9 | 2.1% above |
| 50 week MA | $26.9 | 6.1% above |
| 100 week MA | $25.1 | 13% above |
| 200 week MA | $22.6 | 26% above |
BMRC has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $36.5 | -21% |
| 2021 | $36.5 | $36.6 | +0.4% |
| 2022 | $36.6 | $33.0 | -9.9% |
| 2023 | $33.0 | $22.0 | -33% |
| 2024 | $22.0 | $23.5 | +6.8% |
| 2025 | $23.5 | $26.6 | +13% |
| 2026 YTD | $26.6 | $28.5 | +7.3% |
BMRC has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.